1154990-12-1

Basic information

• Product Name: (1,2,4-Oxadiazol-3-yl)Methanol
• Synonyms: (1,2,4-Oxadiazol-3-yl)Methanol
• CAS NO: 1154990-12-1
• Molecular Formula: C3H4N2O2
• Molecular Weight: 100.07606
• Mol File: 1154990-12-1.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: (1,2,4-Oxadiazol-3-yl)Methanol(CAS DataBase Reference)
• NIST Chemistry Reference: (1,2,4-Oxadiazol-3-yl)Methanol(1154990-12-1)
• EPA Substance Registry System: (1,2,4-Oxadiazol-3-yl)Methanol(1154990-12-1)

Safety Data

• Hazardous Substances Data: 1154990-12-1(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
(1,2,4-Oxadiazol-3-yl)Methanol is used as a building block in the development of new drugs. Its high reactivity enables the synthesis of various bioactive compounds with potential therapeutic applications.
Used in Agrochemical Industry:
(1,2,4-Oxadiazol-3-yl)Methanol is used as a building block in the development of new pesticides. Its ability to undergo various chemical reactions allows for the creation of compounds with specific pesticidal properties.
Used in Materials Science Research:
(1,2,4-Oxadiazol-3-yl)Methanol is used in the production of polymers and materials with specific properties. Its versatility in chemical reactions contributes to the development of materials with tailored characteristics for various applications.

Upstream product

• 89032-81-5 methyl 1,2,4-oxadiazole-3-carboxylate 
• 39512-59-9 ethyl 1,2,4-oxadiazole-3-carboxylate 

Relevant articles and documents

1H-PYRAZOLO[4,3-B]PYRIDINES AS PDE1 INHIBITORS

The present invention provides 1H-pyrazolo[4,3-b]pyridines of formula (I) as PDE1 inhibitors and their use as a medicament, in particular for the treatment of neurodegenerative disorders and psychiatric disorders.

COMBINATION TREATMENTS COMPRISING ADMINISTRATION OF 1H-PYRAZOLO[4,3-B]PYRIDINES

The present invention provides 1H-pyrazolo[4,3-b]pyridin-7-amines of formula (I) as PDE1 inhibitors together with a second compound useful in the treatment of a neurodegenerative disorder and their combined use as a medicament, in particular for the treatment of neurodegenerative and/or cognitive disorders.

COMBINATION TREATMENTS COMPRISING ADMINISTRATION OF 1H-PYRAZOLO[4,3-B]PYRIDINES

The present invention provides 1H-pyrazolo[4,3-b]pyridin-7-amines of formula (I) as PDE1 inhibitors together with a second compound which compound is useful in the treatment of a psychiatric disorder and their combined use as a medicament, in particular for the treatment of psychiatric and/or cognitive disorders.

1H-PYRAZOLO[4,3-B]PYRIDINES AS PDE1 INHIBITORS

The present invention provides 1H-pyrazolo[4,3-b]pyridin-7-amines of formula (I) as PDE1 inhibitors and their use as a medicament, in particular for the treatment of neurodegenerative disorders and psychiatric disorders.